6 Promising Biopharmas With Major Catalysts in 2018 Post author:Sam Post published:January 28, 2018 Post category:BioPharma A look at six biopharma companies that may have major stock catalysts this year. Source: BioSpace You Might Also Like Ablynx Drug Fails Again in Mid-Stage Trial March 25, 2018 Novartis Buys Access to Spark's Landmark Gene Therapy Drug With $170M Deal January 24, 2018 Struggling Teva Loses Top R&D Exec To Eli Lilly, Novartis AG-Backed Cavion August 14, 2017
